Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

FHS
May 3, 2024
10:30 am

Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).

Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCT

Extending the duration of letermovir (Prevymis) prophylaxis following hematopoietic stem cell transplantation (HSCT) was effective in reducing the risk of late clinically significant cytomegalovirus infection,

December 28, 2023

Scripps Research identifies binding site on challenging cancer protein

Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein called Forkhead box protein 1 (FOXA1). FOXA1 mutations can enable

October 15, 2024

Simplified Assessment Tool for Psoriatic Arthritis Performs Well

According to a study presented at the American College of Rheumatology (ACR) annual meeting, the newly developed Psoriatic Arthritis 5-Thermometer Scales (PsA-5Ts) is a simple

November 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.